Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $191M (100.0% shares, 0.0% debt)

Holdings (26)

— AMRYT PHARMA PLC - SPNR ADR 17.7%
Value $33.94M Shares 2,797,744 Share Price $12.13 Est. Cost/Share $13.38 Unrealized @ Report Date —
— CHIASMA INC 16.7%
Value $32.02M Shares 6,770,000 Share Price $4.73 Est. Cost/Share $3.69 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 10.0%
Value $19.08M Shares 7,632,530 Share Price $2.50 Est. Cost/Share $2.48 Unrealized @ Report Date —
— ADAMAS PHARMACEUTICALS INC 7.4%
Value $14.23M Shares 2,694,295 Share Price $5.28 Est. Cost/Share $4.78 Unrealized @ Report Date —
— CATALYST BIOSCIENCES INC 7.0%
Value $13.32M Shares 3,076,376 Share Price $4.33 Est. Cost/Share $4.78 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 5.1%
Value $9.818M Shares 3,305,617 Share Price $2.97 Est. Cost/Share $2.85 Unrealized @ Report Date —
OVID OVID THERAPEUTICS INC 4.1%
Value $7.82M Shares 2,000,000 Share Price $3.91 Est. Cost/Share $3.32 Unrealized @ Report Date +18.8%
— CONFORMIS INC 4.0%
Value $7.62M Shares 6,626,085 Share Price $1.15 Est. Cost/Share $1.04 Unrealized @ Report Date —
— AFFIMED NV 3.8%
Value $7.225M Shares 850,000 Share Price $8.50 Est. Cost/Share $6.95 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 3.2%
Value $6.174M Shares 762,183 Share Price $8.10 Est. Cost/Share $3.98 Unrealized @ Report Date —
XOMA XOMA CORP 2.9%
Value $5.611M Shares 165,041 Share Price $34.00 Est. Cost/Share $20.24 Unrealized @ Report Date +65.4%
CELC CELCUITY INC 2.7%
Value $5.255M Shares 218,951 Share Price $24.00 * Est. Cost/Share $20.00 Unrealized @ Report Date +28.7%
— YUMANITY THERAPEUTICS INC 2.7%
Value $5.149M Shares 441,959 Share Price $11.65 Est. Cost/Share $16.28 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 2.5%
Value $4.792M Shares 200,000 Share Price $23.96 * Est. Cost/Share $26.28 Unrealized @ Report Date -0.4%
— IVERIC BIO INC 1.7%
Value $3.265M Shares 517,445 Share Price $6.31 Est. Cost/Share $1.92 Unrealized @ Report Date —
— ANGION BIOMEDICA CORP 1.5%
Value $2.901M Shares 222,836 Share Price $13.02 Est. Cost/Share $16.08 Unrealized @ Report Date —
— GAMIDA CELL LTD 1.5%
Value $2.843M Shares 443,507 Share Price $6.41 Est. Cost/Share $7.50 Unrealized @ Report Date —
EYPT EYEPOINT PHARMACEUTICALS INC 1.4%
Value $2.732M Shares 303,851 Share Price $8.99 * Est. Cost/Share $11.25 Unrealized @ Report Date -14.7%
XGN EXAGEN INC 1.3%
Value $2.541M Shares 169,542 Share Price $14.99 * Est. Cost/Share $17.82 Unrealized @ Report Date -13.9%
— CIDARA THERAPEUTICS INC 1.3%
Value $2.447M Shares 1,211,286 Share Price $2.02 Est. Cost/Share $2.02 Unrealized @ Report Date —
DMAC DIAMEDICA THERAPEUTICS INC 1.0%
Value $1.869M Shares 419,942 Share Price $4.45 * Est. Cost/Share $4.96 Unrealized @ Report Date +65.5%
— CONTRAFECT CORP 0.2%
Value $296K Shares 67,208 Share Price $4.40 Est. Cost/Share $4.80 Unrealized @ Report Date —
— NEUBASE THERAPEUTICS INC 0.1%
Value $149K Shares 31,070 Share Price $4.80 Est. Cost/Share $4.80 Unrealized @ Report Date —
CRVS CORVUS PHARMACEUTICALS INC 0.1%
Value $125K Shares 46,886 Share Price $2.67 * Est. Cost/Share $3.61 Unrealized @ Report Date -23.8%
— APPLIED GENETIC TECHNOLOGIES 0.0%
Value $4,000 Shares 1,000 Share Price $4.00 Est. Cost/Share $5.07 Unrealized @ Report Date —
SCYX SCYNEXIS INC 0.0%
Value $1,000 Shares 100 Share Price $10.00 * Est. Cost/Share $7.89 Unrealized @ Report Date 0.0%